Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
SFOSF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $10 | $9 | $10 | $10 |
| % Growth | 7.2% | -7.2% | -2.8% | – |
| Cost of Goods Sold | $5 | $5 | $5 | $5 |
| Gross Profit | $5 | $5 | $5 | $5 |
| % Margin | 48.5% | 47.8% | 46.1% | 48.1% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | -$0 | $1 | $1 | $3 |
| SG&A Expenses | -$0 | $3 | -$3 | $7 |
| Sales & Mktg Exp. | $0 | $2 | $2 | $4 |
| Other Operating Expenses | $3 | -$1 | $6 | -$4 |
| Operating Expenses | $3 | $3 | $4 | $4 |
| Operating Income | $1 | $1 | $1 | $1 |
| % Margin | 13.9% | 14.4% | 11.2% | 11.3% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $1 | $1 | $1 | $1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $1 | $1 | $1 | $1 |
| % Margin | 9.3% | 8.1% | 7.5% | 7.5% |
| EPS | 0.35 | 0.29 | 0.29 | 0.3 |
| % Growth | 20.7% | 0% | -3.3% | – |
| EPS Diluted | 0.35 | 0.29 | 0.29 | 0.3 |
| Weighted Avg Shares Out | 3 | 3 | 3 | 3 |
| Weighted Avg Shares Out Dil | 3 | 3 | 3 | 3 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $2 | $2 | $1 | $2 |
| % Margin | 16.8% | 17.8% | 14.4% | 17.4% |